Related Experiment Video
Updated: Mar 3, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
Women's Cardiovascular Health and Cardiac Rehabilitation: a Priority-setting Partnership
Racquel K Brown1,2, Monica Parry3, Paul Oh2,4
1Rehabilitation Sciences Institute, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Insights
Women with cardiovascular disease (CVD) need better access to cardiac rehabilitation (CR). This study identified top research priorities for women
Area of Science:
- Cardiovascular health research
- Public health initiatives
- Patient-centered care
Background:
- Cardiovascular disease (CVD) is a leading cause of preventable death in Canadian women.
- Women access cardiac rehabilitation (CR) at lower rates than men.
- Patient and clinician input is crucial for improving CR for women.
Purpose of the Study:
- To engage people with lived and living experience (PWLLE) of CVD and clinicians in Canada.
- To identify and prioritize research questions for women's CR.
- To inform future research and improve CR accessibility and effectiveness for women.
Main Methods:
- A James Lind Alliance priority setting partnership was employed.
- Two surveys collected questions from PWLLE and clinicians regarding women's CR.
- An in-person workshop prioritized research questions through consensus.
Main Results:
- Initial survey yielded 1347 questions; 715 were summarized into 52 questions.
- Second survey resulted in a shortlist of 25 questions.
- Top 10 priorities identified include individualization, women-only CR, follow-up, referral criteria, education, optimization, nutritional counseling, rural access, and exercise safety/progression.
Conclusions:
- Consensus between PWLLE and clinicians established key research priorities for women's CR.
- These priorities provide a framework for future research.
- Addressing these priorities can enhance cardiovascular health and reduce future events in women.
Background:
Cardiovascular disease (CVD) is the leading cause of preventable deaths in Canadian women. Cardiac rehabilitation (CR) is a risk reduction program that can enhance and maintain cardiovascular health through individualized programming. Participation can reduce future events by up to 50%. However, women are less likely to access CR than men. A collaborative research agenda is needed to address women's priorities for CR, incorporating the input of people with lived and living experience (PWLLE), whose needs are often left unmet. The objective of this study was to engage PWLLE of CVD and clinicians in Canada to identify and prioritize research questions about CR for women.
Methods:
James Lind Alliance priority setting partnership was conducted. An initial survey collected questions about women's CR from PWLLE and clinicians. In a second survey, PWLLE and clinicians shortlisted the questions. The questions were prioritized at in-person workshop.
Results:
The first survey collected 1347 questions from 172 respondents: 74.3% women with lived experience of cardiovascular condition(s) and/or procedure(s), 10.5% family, friends, caregivers, and 23.4% clinicians. Out-of-scope submissions were removed. The remaining 715 were grouped and summarized, resulting in 52 summary questions. There were 250 responses to the second survey, which was used to create a shortlist of 25 questions. At the workshop, PWLLE and clinicians (n = 22) identified the top 10 priorities namely, individualization; women-only CR; follow-up; referral criteria; education; optimization; nutritional counselling; rural access; and exercise safety/progression.
Conclusion:
These priorities were established through PWLLE-clinician consensus and provide a framework for future CR research in women.
More Related Videos
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Rheumatic Heart Disease IV: Nursing Management
Coronary Artery Disease IV: Preventive Measures
Rheumatic Heart Disease III: Medical Management

